The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
Abstract
BACKGROUND: Septic shock represents the major cause of infection-associated mortality in the intensive care unit. The possibility that combination antibiotic therapy of bacterial septic shock improves outcome is controversial. Current guidelines do not recommend combination therapy except for the express purpose of broadening coverage when resistant pathogens are a concern. OBJECTIVE: To evaluate the therapeutic benefit of early combination therapy comprising at least two antibiotics of different mechanisms with in vitro activity for the isolated pathogen in patients with bacterial septic shock. DESIGN: Retrospective, propensity matched, multicenter, cohort study. SETTING: Intensive care units of 28 academic and community hospitals in three countries between 1996 and 2007. SUBJECTS: A total of 4662 eligible cases of culture-positive, bacterial septic shock treated with combination or monotherapy from which 1223 propensity-matched pairs were generated. MEASUREMENTS AND MAIN RESULTS: The primary outcome of study was 28-day mortality. Using a Cox proportional hazards model, combination therapy was associated with decreased 28-day mortality (444 of 1223 [36.3%] vs. 355 of 1223 [29.0%]; hazard ratio, 0.77; 95% confidence interval, 0.67-0.88; p = .0002). The beneficial impact of combination therapy applied to both Gram-positive and Gram-negative infections but was restricted to patients treated with beta-lactams in combination with aminoglycosides, fluoroquinolones, or macrolides/clindamycin. Combination therapy was also associated with significant reductions in intensive care unit (437 of 1223 [35.7%] vs. 352 of 1223 [28.8%]; odds ratio, 0.75; 95% confidence interval, 0.63-0.92; p = .0006) and hospital mortality (584 of 1223 [47.8%] vs. 457 of 1223 [37.4%]; odds ratio, 0.69; 95% confidence interval, 0.59-0.81; p < .0001). The use of combination therapy was associated with increased ventilator (median and [interquartile range], 10 [0-25] vs. 17 [0-26]; p = .008) and pressor/inotrope-free days (median and [interquartile range], 23 [0-28] vs. 25 [0-28]; p = .007) up to 30 days. CONCLUSION: Early combination antibiotic therapy is associated with decreased mortality in septic shock. Prospective randomized trials are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
Statistical methods in cancer research. Volume I - The analysis of case-control studies.
Breslow, N. E., & Day, N. E. (1980) · PubMed · Cited by 4,988
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
The Effectiveness of Right Heart Catheterization in the Initial Care of Critically III Patients
Connors, A. F. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110043030 · Cited by 2,210
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Kumar, A., Ellis, P., Arabi, Y., Roberts, D., Light, B., Parrillo, J. E., Dodek, P., Wood, G., Kumar, A., Simon, D., et al. (2009) · Chest · doi:10.1378/chest.09-0087 · Cited by 1,187
Self-citationReducing bias in a propensity score matched-pair sample using greedy matching techniques
Parsons, L. (2001) · Medical Entomology and Zoology · Cited by 733
Immortal time bias in observational studies of drug effects
Suissa, S. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1357 · Cited by 584
Indications for propensity scores and review of their use in pharmacoepidemiology
Glynn, R. J., Schneeweiss, S., & Stürmer, T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_293.x · Cited by 541
The Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group, Bagshaw, S. M., Lapinsky, S., Dial, S., Arabi, Y., Dodek, P., Wood, G., Ellis, P., Guzman, J., Marshall, J., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1367-2 · Cited by 482
Self-citationDefinitions of infection for surveillance in long-term care facilities
McGeer, A., Campbell, B., Emori, T. G., Hierholzer, W. J., Jackson, M. M., Nicolle, L. E., Peppier, C., Rivera, A., Schollenberger, D. G., Simor, A. E., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90154-5 · Cited by 478
Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Self-citationGram-Negative Bacteremia: II. Clinical, Laboratory, and Therapeutic Observations
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240038007 · Cited by 384
The EORTC International Antimicrobial Therapy Cooperative Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172703 · Cited by 345
Kumar, A., Safdar, N., Kethireddy, S., & Chateau, D. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181e96b91 · Cited by 340
Self-citationPropensity Scores: An Introduction and Experimental Test
Luellen, J. K., Shadish, W. R., & Clark, M. H. (2005) · Evaluation Review · doi:10.1177/0193841x05275596 · Cited by 336
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary
Chow, J. W., & Yu, V. L. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00060-0 · Cited by 320
Immunocompromised animal models for the study of antibiotic combinations.
Calandra, T., & Glauser, M. P. (1986) · PubMed · Cited by 287
Sensory neuronopathy and small cell lung cancer
Graus, F., Elkon, K. B., Cordon-Cardo, C., & Posner, J. B. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90047-1 · Cited by 246
Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm212 · Cited by 229
Labro, M.-T. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.615 · Cited by 224
Development of resistance during antibiotic therapy
Milatovic, D., & Braveny, I. (1987) · European Journal of Clinical Microbiology · doi:10.1007/bf02017607 · Cited by 174
Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia
Anderson, E. T., Young, L. S., & Hewitt, W. L. (1978) · Chemotherapy · doi:10.1159/000237759 · Cited by 173
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes
Khan, A., Slifer, T., Araujo, F., & Remington, J. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00091-0 · Cited by 167
Synergistic Combinations of Antibiotics in Gram-Negative Bacillary Infections
Klastersky, J., & Zinner, S. H. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.2.294 · Cited by 158
Bochud, P., Glauser, M. P., & Calandra, T. (2001) · Intensive Care Medicine · doi:10.1007/pl00003796 · Cited by 155
Nonantimicrobial Effects of Antibacterial Agents
Pasquale, T. R., & Tan, J. S. (2004) · Clinical Infectious Diseases · doi:10.1086/426545 · Cited by 125
Giamarellou, H. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90490-0 · Cited by 118
Gribble, M. J., CHOW, A. W. C., Naiman, S. C., et al. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.3.388 · Cited by 113
Early intravenous unfractionated heparin and mortality in septic shock*
Zarychanski, R., Doucette, S. P., Fergusson, D. A., ROBERTS, D. E., Houston, D. S., Sharma, S., Gulati, H., & Kumar, A. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b8c6b · Cited by 100
Self-citationRUOFF, G. E. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90121-x · Cited by 95
Pankuch, G. A., Lin, G., Seifert, H., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-07 · Cited by 95
The utility of aminoglycosides in an era of emerging drug resistance
Zembower, T., Noskin, G. A., Postelnick, M. J., Nguyen, C., & Peterson, L. R. (1998) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00033-8 · Cited by 81
Archer, G. L., & Fekety, F. R. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.3.327 · Cited by 72
Effect of Trovafloxacin on Production of Cytokines by Human Monocytes
Khan, A. A., Slifer, T. R., & Remington, J. S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1713 · Cited by 72
Weiss, K., & Tillotson, G. S. (2005) · CHEST Journal · doi:10.1378/chest.128.2.940 · Cited by 66
Klebsiella pneumoniae bacteraemia at an urban general hospital
Feldman, C. H., Smith, C. A., Levy, H. A., Ginsburg, P., Miller, S. D., & KOORNHOF, H. J. (1990) · Journal of Infection · doi:10.1016/s0163-4453(90)92258-m · Cited by 50
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
Gradelski, E., Kolek, B., BONNER, D. P., Valera, L., Minassian, B., & Fung-Tomc, J. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00317-4 · Cited by 44
Darras-Joly, C., Bedos, J. P., Sauve, C., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2147 · Cited by 44
MONOTHERAPY VERSUS COMBINATION THERAPY FOR BACTERIAL INFECTIONS
Bouza, E., & Muñóz, P. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70293-5 · Cited by 40
Mufson, M. A., & Stanek, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/499110 · Cited by 31
Monotherapy Versus Combination Therapy
Patel, S. M., & Saravolatz, L. D. (2006) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.07.008 · Cited by 30
Goscinski, G., Lipcsey, M., Eriksson, M. B., Larsson, A. O., Tano, E., & Sjölin, J. (2003) · Critical Care · doi:10.1186/cc2415 · Cited by 23
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationKalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Metadata
- Authors
- Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., Martinka, G., Keenan, S., Wood, G., Arabi, Y., Feinstein, D., Kumar, A., Dodek, P., Kravetsky, L., & Doucette, S.
- Venue
- Critical Care Medicine
- Published
- 2010-09
- Volume
- 38
- Issue
- 9
- Pages
- 1773-1785
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2156416784
- Cited by
- 462
- References
- 51
- FWCI
- 24.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.